Skip to main content

Robin Adelstein is Norton Rose Fulbright’s Global and US Head of Antitrust and Competition.

Robin’s pragmatic approach to the practice of law is informed by her experience, having served as in-house antitrust and litigation counsel at Swiss healthcare company Novartis and UK alcohol beverage leader Diageo before becoming North American General Counsel of Sandoz, the generics and biosimilars division of Novartis.

Whether involving pharmaceuticals, consumer products or other industries, Robin has advised her clients on a wide variety of issues and directed material litigation and government investigations to positive results. As a former General Counsel of a multibillion-dollar company, Robin knows first-hand the importance of providing prompt, accurate and practical advice on legal and compliance issues, particularly in the context of balancing complex business objectives. Robin also understands the challenges with managing outside counsel, having redesigned and run the Novartis Preferred Firm Program globally.


+1-212-318-3108

Robin Adelstein

Global Head of Antitrust and Competition
Norton Rose Fulbright
New York

Practice Area: Antitrust, Competition

All-Star

WHAT CLIENTS SAY

"Robin is a true subject matter expert and a talented trial lawyer."
"She is smart and delivers for us."


ALL-STAR BIOGRAPHY

Robin Adelstein is Norton Rose Fulbright’s Global and US Head of Antitrust and Competition.

Robin’s pragmatic approach to the practice of law is informed by her experience, having served as in-house antitrust and litigation counsel at Swiss healthcare company Novartis and UK alcohol beverage leader Diageo before becoming North American General Counsel of Sandoz, the generics and biosimilars division of Novartis.

Whether involving pharmaceuticals, consumer products or other industries, Robin has advised her clients on a wide variety of issues and directed material litigation and government investigations to positive results. As a former General Counsel of a multibillion-dollar company, Robin knows first-hand the importance of providing prompt, accurate and practical advice on legal and compliance issues, particularly in the context of balancing complex business objectives. Robin also understands the challenges with managing outside counsel, having redesigned and run the Novartis Preferred Firm Program globally.

Visit All-Star's Firm »


+1-212-318-3108

Robin Adelstein

Global Head of Antitrust and Competition
Norton Rose Fulbright
New York

Practice Area: Antitrust, Competition

M&A All-Star

ALL-STAR BIOGRAPHY

Robin Adelstein is Norton Rose Fulbright’s Global and US Head of Antitrust and Competition.

Robin’s pragmatic approach to the practice of law is informed by her experience, having served as in-house antitrust and litigation counsel at Swiss healthcare company Novartis and UK alcohol beverage leader Diageo before becoming North American General Counsel of Sandoz, the generics and biosimilars division of Novartis.

Whether involving pharmaceuticals, consumer products or other industries, Robin has advised her clients on a wide variety of issues and directed material litigation and government investigations to positive results. As a former General Counsel of a multibillion-dollar company, Robin knows first-hand the importance of providing prompt, accurate and practical advice on legal and compliance issues, particularly in the context of balancing complex business objectives. Robin also understands the challenges with managing outside counsel, having redesigned and run the Novartis Preferred Firm Program globally.

Visit All-Star's Firm »